Ketamine/xylazine and barbiturates modulate microglial morphology and motility differently in a mouse model.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 27 03 2020
accepted: 08 07 2020
entrez: 8 8 2020
pubmed: 8 8 2020
medline: 21 10 2020
Statut: epublish

Résumé

Microglia, the resident immune cells of the brain, are highly ramified and motile and their morphology is strongly linked to their function. Microglia constantly monitor the brain parenchyma and are crucial for maintaining brain homeostasis and fine-tuning neuronal networks. Besides affecting neurons, anesthetics may have wide-ranging effects mediated by non-neuronal cells and in particular microglia. We thus examined the effect of two commonly used anesthetic agents, ketamine/xylazine and barbiturates, on microglial motility and morphology. A combination of two-photon in vivo imaging and electroencephalography (EEG) recordings in unanesthetized and anesthetized mice as well as automated analysis of ex vivo sections were used to assess morphology and dynamics of microglia. We found that administration of ketamine/xylazine and pentobarbital anesthesia resulted in quite distinct EEG profiles. Both anesthetics reduced microglial motility, but only ketamine/xylazine administration led to reduction of microglial complexity in vivo. The change of cellular dynamics in vivo was associated with a region-dependent reduction of several features of microglial cells ex vivo, such as the complexity index and the ramification length, whereas thiopental altered the size of the cytoplasm. Our results show that anesthetics have considerable effects on neuronal activity and microglial morphodynamics and that barbiturates may be a preferred anesthetic agent for the study of microglial morphology. These findings will undoubtedly raise compelling questions about the functional relevance of anesthetics on microglial cells in neuronal physiology and anesthesia-induced neurotoxicity.

Identifiants

pubmed: 32760073
doi: 10.1371/journal.pone.0236594
pii: PONE-D-20-08808
pmc: PMC7410236
doi:

Substances chimiques

Anesthetics 0
GABA Modulators 0
Receptors, N-Methyl-D-Aspartate 0
Xylazine 2KFG9TP5V8
Ketamine 690G0D6V8H
Pentobarbital I4744080IR
Thiopental JI8Z5M7NA3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0236594

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist. Micromem is not a commercial source, but the name of the project that is financed by the French National Agency for Research.

Références

J Neurosci. 2014 Aug 6;34(32):10528-40
pubmed: 25100587
J Neurosci. 2014 Aug 6;34(32):10511-27
pubmed: 25100586
J Neuroinflammation. 2016 Jun 17;13(1):153
pubmed: 27317566
Neuron. 2018 Jan 17;97(2):299-312.e6
pubmed: 29290552
Front Cell Neurosci. 2013 May 14;7:65
pubmed: 23717262
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
Sleep. 2002 Sep 15;25(6):617-22
pubmed: 12224840
Curr Neuropharmacol. 2010 Mar;8(1):2-9
pubmed: 20808541
Glia. 2007 Jun;55(8):810-21
pubmed: 17357150
Cereb Cortex. 2005 Sep;15(9):1322-31
pubmed: 15647528
PLoS One. 2011 Jan 25;6(1):e15973
pubmed: 21283568
Exp Neurol. 1996 Feb;137(2):234-41
pubmed: 8635538
J Neurosci. 2011 Oct 19;31(42):14998-5008
pubmed: 22016533
Nature. 2016 Dec 7;540(7632):230-235
pubmed: 27929004
Psychopharmacology (Berl). 1999 Oct;146(3):335-8
pubmed: 10541735
Mediators Inflamm. 2016;2016:3271579
pubmed: 27956760
Cell Rep. 2018 Sep 4;24(10):2773-2783.e6
pubmed: 30184509
Nat Neurosci. 2016 Mar;19(3):504-16
pubmed: 26780511
Neurobiol Aging. 2014 Sep;35(9):2147-60
pubmed: 24799273
Brain Behav Immun. 2019 Oct;81:361-373
pubmed: 31255681
Nat Rev Neurosci. 2010 Apr;11(4):227-38
pubmed: 20300101
Mol Cell Neurosci. 2004 Feb;25(2):312-22
pubmed: 15019947
Epilepsia. 2012 Dec;53 Suppl 8:12-25
pubmed: 23205959
Ann Neurol. 2012 Oct;72(4):536-49
pubmed: 23109148
Eur J Neurosci. 2003 Jun;17(11):2267-76
pubmed: 12814360
Cell. 2013 Dec 19;155(7):1596-609
pubmed: 24360280
Biochim Biophys Acta Biomembr. 2019 Mar 1;1861(3):594-609
pubmed: 30571949
Brain Behav Immun. 2016 Jul;55:126-137
pubmed: 26576722
Nat Neurosci. 2019 Nov;22(11):1782-1792
pubmed: 31636451
Nat Neurosci. 2019 Nov;22(11):1771-1781
pubmed: 31636449
Nat Rev Neurosci. 2016 Oct 18;17(11):705-717
pubmed: 27752068
Anesthesiology. 1997 Oct;87(4):944-51
pubmed: 9357898
Anesthesiology. 1996 Jun;84(6):1411-24
pubmed: 8669683
Lancet Psychiatry. 2018 Apr;5(4):339-347
pubmed: 29496589
Neuroscientist. 2015 Apr;21(2):169-84
pubmed: 24722525
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18974-9
pubmed: 23112168
J Neurosci. 2009 Apr 1;29(13):3974-80
pubmed: 19339593
Anesthesiology. 2000 Apr;92(4):1144-53
pubmed: 10754635
J Biochem. 2001 Aug;130(2):169-75
pubmed: 11481032
Brain Res Bull. 1994;34(1):73-8
pubmed: 8193937
PLoS Biol. 2010 Nov 02;8(11):e1000527
pubmed: 21072242
Nat Neurosci. 2005 Jun;8(6):752-8
pubmed: 15895084
Neuron. 2017 Jul 19;95(2):341-356.e6
pubmed: 28689984
Front Syst Neurosci. 2014 Dec 18;8:237
pubmed: 25565990
World J Crit Care Med. 2012 Jun 04;1(3):80-93
pubmed: 24701405
Lab Anim. 1979 Oct;13(4):317-9
pubmed: 119109
eNeuro. 2018 Oct 25;5(5):
pubmed: 30406198
Pflugers Arch. 2006 Aug;452(5):589-97
pubmed: 16639550
Front Neurosci. 2019 May 07;13:421
pubmed: 31133777
J Biol Chem. 2013 May 24;288(21):15291-302
pubmed: 23548902
Glia. 2013 Aug;61(8):1306-19
pubmed: 23828736
Science. 2005 May 27;308(5726):1314-8
pubmed: 15831717
Lab Anim. 1981 Apr;15(2):163-70
pubmed: 7278122
J Control Release. 2017 Oct 10;263:192-199
pubmed: 28336376
Epilepsy Res Suppl. 1992;8:57-62
pubmed: 1358104
J Pharmacol Exp Ther. 1960 Jan;128:1-6
pubmed: 13850755

Auteurs

Ines Hristovska (I)

Equipe Synaptopathies et Autoanticorps (SynatAc), Institut NeuroMyoGène, INSERM U1217/UMR CNRS 5310, Lyon, France.
Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.

Franck Verdonk (F)

Unité Neuropathologie Expérimentale, Département Infection et Epidémiologie, Institut Pasteur, Paris, France.
Department d'anesthésiologie et de Soins Intensifs, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
Sorbonne Université, Paris, France.
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California, United States of America.

Jean-Christophe Comte (JC)

Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
Equipe Processus d'oubli et Dynamique Corticale, Centre de Recherche en Neuroscience de Lyon (CRNL), INSERM U1028, CNRS UMR5292, Lyon, France.

Eileen S Tsai (ES)

Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California, United States of America.

Virginie Desestret (V)

Equipe Synaptopathies et Autoanticorps (SynatAc), Institut NeuroMyoGène, INSERM U1217/UMR CNRS 5310, Lyon, France.
Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
Centre maladies rares sur les syndromes neurologiques paranéoplasiques, Hospices Civils de Lyon, Lyon, France.

Jérôme Honnorat (J)

Equipe Synaptopathies et Autoanticorps (SynatAc), Institut NeuroMyoGène, INSERM U1217/UMR CNRS 5310, Lyon, France.
Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
Centre maladies rares sur les syndromes neurologiques paranéoplasiques, Hospices Civils de Lyon, Lyon, France.

Fabrice Chrétien (F)

Unité Neuropathologie Expérimentale, Département Infection et Epidémiologie, Institut Pasteur, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Laboratoire Hospitalo-Universitaire de Neuropathologie, Centre Hospitalier Sainte Anne, Paris, France.

Olivier Pascual (O)

Equipe Synaptopathies et Autoanticorps (SynatAc), Institut NeuroMyoGène, INSERM U1217/UMR CNRS 5310, Lyon, France.
Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH